-
New research shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes.
-
A small but growing group of young teens are turning to drastic treatments to lose large amounts of weight, things like body-altering surgery and new drugs that rewire metabolism.
-
The National Eating Disorders Association took down a controversial chatbot, after users showed how the newest version could dispense potentially harmful advice about dieting and calorie counting.
-
Drug shortages are growing in the United States, and experts see no clear path to resolving them. For patients, that could mean more treatment delays, medication switches and other hassles filling a prescription.
-
There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.
-
Journalist Virginia Sole-Smith says efforts to fight childhood obesity have caused kids to absorb an onslaught of body-shaming messages. Her new book is Fat Talk.
-
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
-
The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.
-
WeightWatchers' acquisition of a telehealth company is just the latest commercial push into the market for a new generation of medications that promise significant weight loss.
-
The company is tapping into a red-hot market for drugs that address obesity with the purchase of telehealth operator Sequence, which can prescribe medications such as Ozempic, Wegovy and Trulicity.